MetaADEDB 2.0 @ LMMD
Leuprolide
(RGLRXNKKBLIBQS-XNHQSDQCSA-N)
Structure
SMILES
CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CC(C)C)CCCN=C(N)N
Molecular Formula:
C61H88N16O14
Molecular Weight:
1269.450
Log P:
3.4473
Hydrogen Bond Acceptor:
28
Hydrogen Bond Donor:
16
TPSA:
468.84
CAS Number(s):
74381-53-6
Synonym(s)
1.
Leuprolide
2.
Leuprorelin
3.
A-43818
4.
Enantone
5.
Leuprolide Acetate
6.
Leuprolide Monoacetate
7.
Leuprolide, (DL-Leu)-Isomer
8.
Leuprolide, (L-Leu)-Isomer
9.
Lupron
10.
TAP-144
11.
A 43818
12.
A43818
13.
Acetate, Leuprolide
14.
Monoacetate, Leuprolide
15.
TAP 144
16.
TAP144
External Link(s)
MeSHD016729
PubChem Compound657180
BindingDB50247891
ChEBI63597
CHEMBLCHEMBL1200775
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 168
Canada Vigilance: 3
Canada Vigilance
US FAERS
2ArthralgiaFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
3FatigueFAERS: 102OFFSIDES
US FAERS
4PainFAERS: 94
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
5NauseaFAERS: 58US FAERS
6Drug ineffectiveFAERS: 57
Canada Vigilance: 4
Canada Vigilance
US FAERS
7Mood swingsFAERS: 53US FAERS
8Feeling abnormalFAERS: 51US FAERS
9DizzinessFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
10AstheniaFAERS: 45
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
11Bone painFAERS: 45OFFSIDES
US FAERS
12MyalgiaFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
13Back PainFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
14EndometriosisFAERS: 37OFFSIDES
US FAERS
15Memory impairmentFAERS: 37US FAERS
16PneumoniaFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
17MalaiseFAERS: 36US FAERS
18AmnesiaFAERS: 35OFFSIDES
US FAERS
19AnxietyFAERS: 34
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
20Injection site painFAERS: 33US FAERS
21Night sweatsFAERS: 31US FAERS
22VomitingFAERS: 30US FAERS
23AlopeciaFAERS: 29US FAERS
24Abdominal PainFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
25HysterectomyFAERS: 27US FAERS
26Myocardial InfarctionFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
27MenorrhagiaFAERS: 24US FAERS
28Impaired work abilityFAERS: 23US FAERS
29CryingFAERS: 22US FAERS
30Chest PainFAERS: 19US FAERS
31Pelvic PainFAERS: 19US FAERS
32Unevaluable eventFAERS: 19
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
33Musculoskeletal stiffnessFAERS: 18US FAERS
34OsteoporosisFAERS: 18OFFSIDES
US FAERS
35ConstipationFAERS: 17US FAERS
36Emotional disorderFAERS: 17US FAERS
37Injection site erythemaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
38PruritusFAERS: 17US FAERS
39Weight decreasedFAERS: 17US FAERS
40AscitesFAERS: 16US FAERS
41Cerebral InfarctionFAERS: 15US FAERS
42Cerebrovascular accidentFAERS: 15US FAERS
43MarasmusFAERS: 15US FAERS
44Respiratory FailureFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
45ChillsFAERS: 14US FAERS
46Diabetes MellitusFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
47Hormone level abnormalFAERS: 14US FAERS
48FractureFAERS: 13US FAERS
49Injection Site ReactionFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Medication ErrorFAERS: 13US FAERS
51Visual ImpairmentFAERS: 13US FAERS
52Injection site abscessFAERS: 12US FAERS
53MenopauseFAERS: 12US FAERS
54PalpitationsFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
55Depressed moodFAERS: 11US FAERS
56HypersensitivityFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Incorrect route of drug administrationFAERS: 11US FAERS
58Injection site noduleFAERS: 11OFFSIDES
US FAERS
59SomnolenceFAERS: 11US FAERS
60SwellingFAERS: 11US FAERS
61SyncopeFAERS: 11US FAERS
62AngerFAERS: 10US FAERS
63Disease ProgressionFAERS: 10OFFSIDES
US FAERS
64General physical health deteriorationFAERS: 10OFFSIDES
US FAERS
65Joint swellingFAERS: 10US FAERS
66Pulmonary EmbolismFAERS: 10US FAERS
67Drug exposure during pregnancyFAERS: 9US FAERS
68Erectile dysfunctionFAERS: 9OFFSIDES
US FAERS
69ErythemaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
70MetrorrhagiaFAERS: 9US FAERS
71Musculoskeletal PainFAERS: 9OFFSIDES
US FAERS
72ThrombosisFAERS: 9US FAERS
73AbasiaFAERS: 8US FAERS
74AbscessFAERS: 8OFFSIDES
US FAERS
75AcneFAERS: 8US FAERS
76Blood creatine phosphokinase increasedFAERS: 8US FAERS
77Deep Vein ThrombosisFAERS: 8US FAERS
78HungerFAERS: 8US FAERS
79HyperthyroidismFAERS: 8US FAERS
80HypotensionFAERS: 8US FAERS
81Urinary IncontinenceFAERS: 8US FAERS
82Urinary tract infectionFAERS: 8US FAERS
83Activities of daily living impairedFAERS: 7OFFSIDES
US FAERS
84Adverse eventFAERS: 7US FAERS
85CholecystitisFAERS: 7US FAERS
86CystFAERS: 7OFFSIDES
US FAERS
87HerniaFAERS: 7US FAERS
88Neck PainFAERS: 7US FAERS
89Pancreatic carcinomaFAERS: 7US FAERS
90TachycardiaFAERS: 7US FAERS
91TremorFAERS: 7US FAERS
92AphasiaFAERS: 6US FAERS
93Blood testosterone increasedFAERS: 6US FAERS
94CataractFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
95CyanosisFAERS: 6US FAERS
96Dry skinFAERS: 6US FAERS
97Emotional distressFAERS: 6OFFSIDES
US FAERS
98EpistaxisFAERS: 6US FAERS
99FlatulenceFAERS: 6US FAERS
100Injury associated with deviceFAERS: 6US FAERS
101Intestinal ObstructionFAERS: 6US FAERS
102PregnancyFAERS: 6US FAERS
103RhabdomyolysisFAERS: 6US FAERS
104ArthritisFAERS: 5US FAERS
105Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
106BlindnessFAERS: 5US FAERS
107Blood cholesterol increasedFAERS: 5US FAERS
108Bone density decreasedFAERS: 5OFFSIDES
US FAERS
109Breast tendernessFAERS: 5US FAERS
110Cardiac ArrestFAERS: 5US FAERS
111Chest discomfortFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
112DiplopiaFAERS: 5US FAERS
113DisorientationFAERS: 5US FAERS
114GoutFAERS: 5US FAERS
115GranulomaFAERS: 5US FAERS
116Grip strength decreasedFAERS: 5US FAERS
117Injection site pruritusFAERS: 5US FAERS
118MetastasisFAERS: 5US FAERS
119Metastatic NeoplasmFAERS: 5OFFSIDES
US FAERS
120MyomectomyFAERS: 5US FAERS
121OsteopeniaFAERS: 5OFFSIDES
US FAERS
122PeritonitisFAERS: 5US FAERS
123Quality of life decreasedFAERS: 5OFFSIDES
US FAERS
124SepsisFAERS: 5US FAERS
125StressFAERS: 5US FAERS
126TinnitusFAERS: 5US FAERS
127UrticariaFAERS: 5US FAERS
128Vulvovaginal drynessFAERS: 5US FAERS
129Abdominal discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
130Alanine Aminotransferase IncreasedFAERS: 4US FAERS
131Angina PectorisFAERS: 4US FAERS
132AnorexiaFAERS: 4US FAERS
133ArteriosclerosisFAERS: 4OFFSIDES
US FAERS
134ArthropathyFAERS: 4OFFSIDES
US FAERS
135Atrial FibrillationFAERS: 4US FAERS
136Coronary Artery DiseaseFAERS: 4US FAERS
137DeafnessFAERS: 4OFFSIDES
US FAERS
138DehydrationFAERS: 4US FAERS
139DeliriumFAERS: 4US FAERS
140DysarthriaFAERS: 4US FAERS
141DysuriaFAERS: 4US FAERS
142EpilepsyFAERS: 4US FAERS
143Feeling ColdFAERS: 4US FAERS
144FibromyalgiaFAERS: 4US FAERS
145FlushingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
146FormicationFAERS: 4OFFSIDES
US FAERS
147Gamma-Glutamyltransferase IncreasedFAERS: 4US FAERS
148Guillain-Barre SyndromeFAERS: 4US FAERS
149HemiplegiaFAERS: 4US FAERS
150HepatitisFAERS: 4US FAERS
151HypoxiaFAERS: 4US FAERS
152Impaired quality of lifeFAERS: 4US FAERS
153Inappropriate schedule of drug administrationFAERS: 4US FAERS
154Incorrect dose administeredFAERS: 4US FAERS
155Injection site bruisingFAERS: 4US FAERS
156Injection site inflammationFAERS: 4US FAERS
157LethargyFAERS: 4OFFSIDES
US FAERS
158LymphadenopathyFAERS: 4US FAERS
159Metastatic painFAERS: 4US FAERS
160Muscle tightnessFAERS: 4US FAERS
161MyopathyFAERS: 4US FAERS
162NocturiaFAERS: 4OFFSIDES
US FAERS
163Post procedural complicationFAERS: 4US FAERS
164PurulenceFAERS: 4US FAERS
165Retinal Vein OcclusionFAERS: 4US FAERS
166ThirstFAERS: 4US FAERS
167Urinary RetentionFAERS: 4US FAERS
168VertigoFAERS: 4US FAERS
169Visual disturbanceFAERS: 4US FAERS
170Wheelchair userFAERS: 4US FAERS
171Abdominal adhesionsFAERS: 3US FAERS
172Acute respiratory failureFAERS: 3US FAERS
173Adnexa uteri painFAERS: 3OFFSIDES
US FAERS
174AnhedoniaFAERS: 3OFFSIDES
US FAERS
175Aortic AneurysmFAERS: 3OFFSIDES
US FAERS
176AsthmaFAERS: 3US FAERS
177BedriddenFAERS: 3US FAERS
178Bipolar DisorderFAERS: 3US FAERS
179Blood alkaline phosphatase increasedFAERS: 3US FAERS
180Blood glucose increasedFAERS: 3US FAERS
181Blood lactate dehydrogenase increasedFAERS: 3US FAERS
182Blood urine presentFAERS: 3US FAERS
183BradycardiaFAERS: 3US FAERS
184Burning sensationFAERS: 3US FAERS
185CholelithiasisFAERS: 3US FAERS
186DementiaFAERS: 3US FAERS
187Diabetes InsipidusFAERS: 3US FAERS
188DisabilityFAERS: 3US FAERS
189DiscomfortFAERS: 3US FAERS
190Disease recurrenceFAERS: 3US FAERS
191Disseminated Intravascular CoagulationFAERS: 3US FAERS
192Drug dispensing errorFAERS: 3US FAERS
193DysgeusiaFAERS: 3US FAERS
194Food cravingFAERS: 3US FAERS
195GingivitisFAERS: 3US FAERS
196Hypothalamo-pituitary disorderFAERS: 3US FAERS
197HypothyroidismFAERS: 3US FAERS
198Impaired driving abilityFAERS: 3US FAERS
199InfectionFAERS: 3OFFSIDES
US FAERS
200Injection site dischargeFAERS: 3US FAERS
201Injection site necrosisFAERS: 3US FAERS
202Injection site warmthFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
203Joint Range of Motion DecreasedFAERS: 3OFFSIDES
US FAERS
204Joint stiffnessFAERS: 3US FAERS
205Leukocytoclastic vasculitisFAERS: 3US FAERS
206LeukopeniaFAERS: 3US FAERS
207MeningiomaFAERS: 3US FAERS
208MeningitisFAERS: 3US FAERS
209Mycosis FungoidesFAERS: 3US FAERS
210NecrosisFAERS: 3US FAERS
211NervousnessFAERS: 3US FAERS
212NeuralgiaFAERS: 3OFFSIDES
US FAERS
213Ovarian Hyperstimulation SyndromeFAERS: 3OFFSIDES
US FAERS
214Ovarian failureFAERS: 3US FAERS
215ParaplegiaFAERS: 3US FAERS
216Personality ChangeFAERS: 3US FAERS
217PhotophobiaFAERS: 3US FAERS
218Poor quality sleepFAERS: 3US FAERS
219Posterior reversible encephalopathy syndromeFAERS: 3US FAERS
220Product quality issueFAERS: 3US FAERS
221Product storage errorFAERS: 3US FAERS
222Psychiatric symptomFAERS: 3US FAERS
223Recall phenomenonFAERS: 3US FAERS
224SciaticaFAERS: 3US FAERS
225ShockFAERS: 3US FAERS
226Sudden Cardiac DeathFAERS: 3US FAERS
227Suicide attemptFAERS: 3US FAERS
228Temperature intoleranceFAERS: 3US FAERS
229Tooth LossFAERS: 3US FAERS
230Venous ThrombosisFAERS: 3US FAERS
231Vitamin D DeficiencyFAERS: 3US FAERS
232nervous system disorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
233Abnormal weight gainFAERS: 2US FAERS
234Accidental overdoseFAERS: 2US FAERS
235AgeusiaFAERS: 2US FAERS
236AgitationFAERS: 2US FAERS
237Altered visual depth perceptionFAERS: 2US FAERS
238Ankle FractureFAERS: 2US FAERS
239AnuriaFAERS: 2US FAERS
240AphoniaFAERS: 2US FAERS
241AtelectasisFAERS: 2US FAERS
242Basal cell carcinomaFAERS: 2OFFSIDES
US FAERS
243Benign Prostatic HyperplasiaFAERS: 2OFFSIDES
US FAERS
244Bladder painFAERS: 2US FAERS
245BlepharospasmFAERS: 2US FAERS
246Blood creatinine increasedFAERS: 2US FAERS
247Blood growth hormone increasedFAERS: 2US FAERS
248Blood potassium decreasedFAERS: 2US FAERS
249Blood prolactin increasedFAERS: 2US FAERS
250Blood testosterone decreasedFAERS: 2US FAERS
251Blood testosterone normalFAERS: 2US FAERS
252Blood urea increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
253BronchopneumoniaFAERS: 2US FAERS
254Bulbospinal muscular atrophy congenitalFAERS: 2US FAERS
255ChorioamnionitisFAERS: 2US FAERS
256Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
257Cold sweatFAERS: 2US FAERS
258Completed SuicideFAERS: 2US FAERS
259Dental cariesFAERS: 2OFFSIDES
US FAERS
260Diabetes mellitus inadequate controlFAERS: 2US FAERS
261Drug dose omissionFAERS: 2US FAERS
262Drug effect incompleteFAERS: 2US FAERS
263Drug ineffective for unapproved indicationFAERS: 2US FAERS
264Drug withdrawal syndromeFAERS: 2US FAERS
265DysphemiaFAERS: 2US FAERS
266DysphoniaFAERS: 2OFFSIDES
US FAERS
267Ectopic PregnancyFAERS: 2US FAERS
268Elevated moodFAERS: 2US FAERS
269EmbolismFAERS: 2US FAERS
270EndocarditisFAERS: 2US FAERS
271EructationFAERS: 2US FAERS
272Essential HypertensionFAERS: 2US FAERS
273Expired product administeredFAERS: 2US FAERS
274Facial PainFAERS: 2US FAERS
275Feeling of body temperature changeFAERS: 2OFFSIDES
US FAERS
276FrustrationFAERS: 2US FAERS
277GastritisFAERS: 2US FAERS
278General symptomFAERS: 2US FAERS
279HepatomegalyFAERS: 2US FAERS
280HydrothoraxFAERS: 2US FAERS
281HypophagiaFAERS: 2US FAERS
282HypopituitarismFAERS: 2US FAERS
283ImpatienceFAERS: 2US FAERS
284IncontinenceFAERS: 2OFFSIDES
US FAERS
285Incorrect drug administration durationFAERS: 2US FAERS
286IndurationFAERS: 2US FAERS
287InflammationFAERS: 2US FAERS
288Injection site granulomaFAERS: 2US FAERS
289Injection site papuleFAERS: 2US FAERS
290Intervertebral Disc DegenerationFAERS: 2US FAERS
291Intervertebral disc disorderFAERS: 2OFFSIDES
US FAERS
292Intestinal PerforationFAERS: 2US FAERS
293Irritable Bowel SyndromeFAERS: 2US FAERS
294KetoacidosisFAERS: 2US FAERS
295LaparoscopyFAERS: 2US FAERS
296Live BirthFAERS: 2US FAERS
297Liver AbscessFAERS: 2US FAERS
298Lobar PneumoniaFAERS: 2US FAERS
299MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
300Macular degenerationFAERS: 2US FAERS
301Mediastinal massFAERS: 2US FAERS
302Mental status changesFAERS: 2US FAERS
303MyositisFAERS: 2US FAERS
304Needle issueFAERS: 2US FAERS
305Nephrotic SyndromeFAERS: 2US FAERS
306Nerve injuryFAERS: 2US FAERS
307NeuropathyFAERS: 2US FAERS
308Nipple painFAERS: 2US FAERS
309Obsessive-Compulsive DisorderFAERS: 2US FAERS
310Oropharyngeal painFAERS: 2OFFSIDES
US FAERS
311Ovarian enlargementFAERS: 2US FAERS
312OverdoseFAERS: 2US FAERS
313OverweightFAERS: 2US FAERS
314ParanoiaFAERS: 2US FAERS
315Pelvic adhesionsFAERS: 2US FAERS
316Pelvic discomfortFAERS: 2US FAERS
317Peripheral swellingFAERS: 2US FAERS
318Physical disabilityFAERS: 2OFFSIDES
US FAERS
319PneumonitisFAERS: 2US FAERS
320PneumothoraxFAERS: 2OFFSIDES
US FAERS
321Postoperative adhesionFAERS: 2US FAERS
322Postoperative feverFAERS: 2US FAERS
323Premature MenopauseFAERS: 2US FAERS
324Prostatic specific antigen decreasedFAERS: 2US FAERS
325Rash erythematousFAERS: 2US FAERS
326Renal cystFAERS: 2OFFSIDES
US FAERS
327Rheumatoid ArthritisFAERS: 2US FAERS
328RhinoscleromaFAERS: 2US FAERS
329Right ventricular failureFAERS: 2US FAERS
330Rotator cuff syndromeFAERS: 2US FAERS
331Secretion dischargeFAERS: 2OFFSIDES
US FAERS
332Serotonin SyndromeFAERS: 2US FAERS
333Sexual DysfunctionFAERS: 2US FAERS
334Skin IndurationFAERS: 2OFFSIDES
US FAERS
335Skin lesionFAERS: 2US FAERS
336SluggishnessFAERS: 2US FAERS
337SomnambulismFAERS: 2US FAERS
338Spinal column stenosisFAERS: 2OFFSIDES
US FAERS
339Spinal cord paralysisFAERS: 2US FAERS
340Stevens-Johnson SyndromeFAERS: 2US FAERS
341Subcutaneous noduleFAERS: 2OFFSIDES
US FAERS
342Sudden onset of sleepFAERS: 2US FAERS
343TachyphreniaFAERS: 2US FAERS
344Temperature regulation disorderFAERS: 2US FAERS
345Therapy cessationFAERS: 2US FAERS
346Therapy non-responderFAERS: 2US FAERS
347TonsillectomyFAERS: 2US FAERS
348UrethrotomyFAERS: 2US FAERS
349Urine flow decreasedFAERS: 2US FAERS
350Urine output increasedFAERS: 2US FAERS
351Uterine PolypFAERS: 2US FAERS
352Uterine spasmFAERS: 2US FAERS
353Vitreous floatersFAERS: 2US FAERS
354Vocal cord cystFAERS: 2US FAERS
355Vulvovaginal painFAERS: 2OFFSIDES
US FAERS
356Walking aid userFAERS: 2US FAERS
357Wrong drug administeredFAERS: 2US FAERS
358Wrong technique in product usage processFAERS: 2US FAERS
359colonoscopyFAERS: 2US FAERS
360liposarcomaFAERS: 2US FAERS
361treatment failureFAERS: 2US FAERS
362AbuliaFAERS: 1US FAERS
363Acanthosis NigricansFAERS: 1US FAERS
364Accidental exposureFAERS: 1US FAERS
365Accidental needle stickFAERS: 1US FAERS
366Acute kidney injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Acute myocardial infarctionFAERS: 1US FAERS
368Administration site pruritusFAERS: 1US FAERS
369Administration site swellingFAERS: 1US FAERS
370Administration site ulcerFAERS: 1US FAERS
371Adnexa uteri massFAERS: 1US FAERS
372AkathisiaFAERS: 1US FAERS
373Allergic respiratory symptomFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Amyotrophic Lateral SclerosisFAERS: 1US FAERS
375Anaphylactic shockFAERS: 1US FAERS
376AneurysmFAERS: 1US FAERS
377AngioedemaFAERS: 1US FAERS
378Aortic valve sclerosisFAERS: 1US FAERS
379ApathyFAERS: 1US FAERS
380Arthropod biteFAERS: 1US FAERS
381AsbestosisFAERS: 1US FAERS
382Atrophic vulvovaginitisFAERS: 1US FAERS
383Autoimmune thyroiditisFAERS: 1US FAERS
384Autonomic nervous system imbalanceFAERS: 1US FAERS
385Autonomic neuropathyFAERS: 1US FAERS
386Back disorderFAERS: 1US FAERS
387BankruptcyFAERS: 1US FAERS
388Biopsy prostate abnormalFAERS: 1US FAERS
389Bladder spasmFAERS: 1US FAERS
390Blood albumin decreasedFAERS: 1US FAERS
391Blood calcitonin increasedFAERS: 1US FAERS
392Blood follicle stimulating hormone increasedFAERS: 1US FAERS
393Blood pressure fluctuationFAERS: 1US FAERS
394Blood pressure inadequately controlledFAERS: 1US FAERS
395Blood sodium decreasedFAERS: 1US FAERS
396Blood triglycerides increasedFAERS: 1US FAERS
397Body height below normalFAERS: 1US FAERS
398Body temperature fluctuationFAERS: 1US FAERS
399Bone lesionFAERS: 1OFFSIDES
US FAERS
400BrachytherapyFAERS: 1US FAERS
401Brain ContusionFAERS: 1US FAERS
402Breakthrough PainFAERS: 1US FAERS
403Breast CystFAERS: 1US FAERS
404BronchitisFAERS: 1US FAERS
405Bronchopulmonary AspergillosisFAERS: 1US FAERS
406C-reactive protein decreasedFAERS: 1US FAERS
407CD30 expressionFAERS: 1US FAERS
408CachexiaFAERS: 1US FAERS
409CalcinosisFAERS: 1US FAERS
410Cancer PainFAERS: 1OFFSIDES
US FAERS
411Capillary FragilityFAERS: 1US FAERS
412Carbohydrate antigen 19-9 increasedFAERS: 1US FAERS
413CardiomegalyFAERS: 1US FAERS
414CellulitisFAERS: 1US FAERS
415Central nervous system lesionFAERS: 1US FAERS
416Central venous catheter removalFAERS: 1US FAERS
417Cerebellar infarctionFAERS: 1US FAERS
418Cervical polypFAERS: 1US FAERS
419ChokingFAERS: 1OFFSIDES
US FAERS
420CholestasisFAERS: 1US FAERS
421Chronic left ventricular failureFAERS: 1US FAERS
422Cluster HeadacheFAERS: 1US FAERS
423ColitisFAERS: 1US FAERS
424Colon adenomaFAERS: 1US FAERS
425Colonic Pseudo-ObstructionFAERS: 1US FAERS
426Complication associated with deviceFAERS: 1US FAERS
427Compulsive sexual behaviourFAERS: 1US FAERS
428Contact lens intoleranceFAERS: 1US FAERS
429Cor pulmonaleFAERS: 1US FAERS
430Corneal dystrophyFAERS: 1US FAERS
431CystitisFAERS: 1US FAERS
432CystoscopyFAERS: 1US FAERS
433CytopeniaFAERS: 1US FAERS
434Decompressive CraniectomyFAERS: 1US FAERS
435DependenceFAERS: 1US FAERS
436Depressed Level of ConsciousnessFAERS: 1US FAERS
437DermatomyositisFAERS: 1US FAERS
438Device malfunctionFAERS: 1US FAERS
439Disease complicationFAERS: 1US FAERS
440Drug exposure before pregnancyFAERS: 1US FAERS
441Drug implantationFAERS: 1US FAERS
442DyscheziaFAERS: 1US FAERS
443DyspepsiaFAERS: 1US FAERS
444EcchymosisFAERS: 1US FAERS
445Economic problemFAERS: 1US FAERS
446Embolic strokeFAERS: 1US FAERS
447Empty Sella SyndromeFAERS: 1US FAERS
448Endometrial HyperplasiaFAERS: 1US FAERS
449Endometrial metaplasiaFAERS: 1US FAERS
450Epidermal necrosisFAERS: 1US FAERS
451EscharFAERS: 1US FAERS
452Euphoric moodFAERS: 1US FAERS
453Exposure during breast feedingFAERS: 1US FAERS
454Eye painFAERS: 1US FAERS
455Eyelid Function DisorderFAERS: 1US FAERS
456Facial paralysisFAERS: 1US FAERS
457Feeding disorder neonatalFAERS: 1US FAERS
458FibromatosisFAERS: 1US FAERS
459Gait inabilityFAERS: 1US FAERS
460GastroenteritisFAERS: 1OFFSIDES
US FAERS
461Gastrointestinal PainFAERS: 1US FAERS
462General physical condition abnormalFAERS: 1US FAERS
463Genital atrophyFAERS: 1US FAERS
464Genital swellingFAERS: 1US FAERS
465Gluten sensitivityFAERS: 1US FAERS
466HELLP SyndromeFAERS: 1US FAERS
467Head discomfortFAERS: 1US FAERS
468Hepatic necrosisFAERS: 1US FAERS
469High density lipoprotein increasedFAERS: 1US FAERS
470Hilar lymphadenopathyFAERS: 1US FAERS
471HirsutismFAERS: 1US FAERS
472Histiocytosis haematophagicFAERS: 1US FAERS
473Hodgkin's disease nodular sclerosis stage IVFAERS: 1US FAERS
474Hospice CareFAERS: 1US FAERS
475HostilityFAERS: 1US FAERS
476HydrocephalusFAERS: 1US FAERS
477HydrometraFAERS: 1US FAERS
478HyperchlorhydriaFAERS: 1US FAERS
479HypersomniaFAERS: 1US FAERS
480HypertrichosisFAERS: 1US FAERS
481HyperventilationFAERS: 1US FAERS
482IleusFAERS: 1US FAERS
483Immune thrombocytopenic purpuraFAERS: 1US FAERS
484ImmunosuppressionFAERS: 1US FAERS
485Impaired gastric emptyingFAERS: 1US FAERS
486Inappropriate schedule of product administrationFAERS: 1US FAERS
487Incision site infectionFAERS: 1US FAERS
488IncoherentFAERS: 1US FAERS
489Incorrect drug dosage form administeredFAERS: 1US FAERS
490Incorrect route of product administrationFAERS: 1US FAERS
491Infected lymphoceleFAERS: 1US FAERS
492Infection in an immunocompromised hostFAERS: 1US FAERS
493InfertilityFAERS: 1US FAERS
494InfluenzaFAERS: 1US FAERS
495Infusion site erythemaFAERS: 1US FAERS
496Injection site cellulitisFAERS: 1US FAERS
497Injection site discomfortFAERS: 1US FAERS
498Injection site eczemaFAERS: 1US FAERS
499Injection site extravasationFAERS: 1US FAERS
500Injection site massFAERS: 1US FAERS
501Injection site ulcerFAERS: 1US FAERS
502Intentional product use issueFAERS: 1US FAERS
503Intentional self-injuryFAERS: 1US FAERS
504Intercepted drug dispensing errorFAERS: 1US FAERS
505Intestinal fibrosisFAERS: 1US FAERS
506Intestinal resectionFAERS: 1US FAERS
507Intracranial artery dissectionFAERS: 1US FAERS
508Intracranial injuryFAERS: 1US FAERS
509Keratoconjunctivitis SiccaFAERS: 1US FAERS
510LaparotomyFAERS: 1US FAERS
511Late onset hypogonadism syndromeFAERS: 1US FAERS
512LeukocytosisFAERS: 1US FAERS
513LeukoplakiaFAERS: 1US FAERS
514Limb operationFAERS: 1US FAERS
515Lip swellingFAERS: 1US FAERS
516Lipase increasedFAERS: 1US FAERS
517Liver palpable subcostalFAERS: 1US FAERS
518Loop electrosurgical excision procedureFAERS: 1US FAERS
519Loose toothFAERS: 1OFFSIDES
US FAERS
520Lymphocyte stimulation test positiveFAERS: 1US FAERS
521MacroangiopathyFAERS: 1US FAERS
522Malignant neoplasm progressionFAERS: 1OFFSIDES
US FAERS
523MegacolonFAERS: 1US FAERS
524Mental impairmentFAERS: 1US FAERS
525Metabolic alkalosisFAERS: 1US FAERS
526MetaplasiaFAERS: 1US FAERS
527Middle insomniaFAERS: 1US FAERS
528Mitochondrial DNA mutationFAERS: 1US FAERS
529MoaningFAERS: 1US FAERS
530MonoplegiaFAERS: 1US FAERS
531Multi-organ disorderFAERS: 1US FAERS
532Multiple SclerosisFAERS: 1US FAERS
533Multiple sclerosis relapseFAERS: 1US FAERS
534Muscle RigidityFAERS: 1US FAERS
535Muscle necrosisFAERS: 1US FAERS
536Musculoskeletal discomfortFAERS: 1OFFSIDES
US FAERS
537Myasthenia GravisFAERS: 1US FAERS
538NasopharyngitisFAERS: 1US FAERS
539NephritisFAERS: 1US FAERS
540NephrolithiasisFAERS: 1US FAERS
541Nicotine DependenceFAERS: 1US FAERS
542No adverse eventFAERS: 1US FAERS
543No reaction on previous exposure to drugFAERS: 1US FAERS
544NoduleFAERS: 1US FAERS
545NystagmusFAERS: 1US FAERS
546ObesityFAERS: 1US FAERS
547Occupational exposure to productFAERS: 1US FAERS
548OliguriaFAERS: 1US FAERS
549OnychoclasisFAERS: 1US FAERS
550Osteoma cutisFAERS: 1OFFSIDES
US FAERS
551Ovarian adhesionFAERS: 1US FAERS
552Ovulation disorderFAERS: 1US FAERS
553PO2 decreasedFAERS: 1US FAERS
554PachymeningitisFAERS: 1US FAERS
555PallorFAERS: 1US FAERS
556PancytopeniaFAERS: 1US FAERS
557ParakeratosisFAERS: 1US FAERS
558Partner stressFAERS: 1US FAERS
559Pathological fractureFAERS: 1US FAERS
560Patient dissatisfaction with treatmentFAERS: 1US FAERS
561Pelvic InfectionFAERS: 1US FAERS
562Performance status decreasedFAERS: 1US FAERS
563Perineal painFAERS: 1US FAERS
564Peripheral artery stenosisFAERS: 1US FAERS
565PetechiaeFAERS: 1US FAERS
566Pharmaceutical product complaintFAERS: 1US FAERS
567Pituitary enlargementFAERS: 1US FAERS
568PolymyalgiaFAERS: 1US FAERS
569PolyneuropathyFAERS: 1US FAERS
570Poor peripheral circulationFAERS: 1US FAERS
571Post-Traumatic Stress DisorderFAERS: 1US FAERS
572PouchitisFAERS: 1US FAERS
573Pre-existing condition improvedFAERS: 1US FAERS
574Precancerous cells presentFAERS: 1US FAERS
575Precocious PubertyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
576Premenstrual painFAERS: 1US FAERS
577Premenstrual syndromeFAERS: 1US FAERS
578PresyncopeFAERS: 1US FAERS
579Product container seal issueFAERS: 1US FAERS
580Product formulation issueFAERS: 1US FAERS
581Product physical consistency issueFAERS: 1US FAERS
582Product use complaintFAERS: 1US FAERS
583Product use in unapproved indicationFAERS: 1US FAERS
584Product use issueFAERS: 1US FAERS
585Prostate cancer recurrentFAERS: 1OFFSIDES
US FAERS
586ProstatectomyFAERS: 1US FAERS
587Protein urine presentFAERS: 1US FAERS
588Pulmonary HypertensionFAERS: 1US FAERS
589PurpuraFAERS: 1US FAERS
590Radical hysterectomyFAERS: 1US FAERS
591Radical prostatectomyFAERS: 1US FAERS
592Renal ColicFAERS: 1US FAERS
593RestlessnessFAERS: 1US FAERS
594Retinal DegenerationFAERS: 1US FAERS
595Retinal vascular thrombosisFAERS: 1US FAERS
596RosaceaFAERS: 1US FAERS
597SalpingectomyFAERS: 1US FAERS
598Salpingo-oophorectomy unilateralFAERS: 1US FAERS
599SarcoidosisFAERS: 1US FAERS
600Schizoaffective DisorderFAERS: 1US FAERS
601SchizophreniaFAERS: 1US FAERS
602ScreamingFAERS: 1US FAERS
603Scrotal massFAERS: 1US FAERS
604Senile dementiaFAERS: 1US FAERS
605Serum SicknessFAERS: 1US FAERS
606Sjogren's SyndromeFAERS: 1US FAERS
607Skin ErosionFAERS: 1US FAERS
608Skin necrosisFAERS: 1US FAERS
609Soft tissue necrosisFAERS: 1US FAERS
610SplenomegalyFAERS: 1US FAERS
611SpondylitisFAERS: 1US FAERS
612Squamous cell carcinomaFAERS: 1US FAERS
613Staphylococcal abscessFAERS: 1US FAERS
614StillbirthFAERS: 1US FAERS
615StrabismusFAERS: 1US FAERS
616Subcutaneous AbscessFAERS: 1US FAERS
617SubileusFAERS: 1US FAERS
618Supraventricular tachycardiaFAERS: 1US FAERS
619Tardive DyskinesiaFAERS: 1US FAERS
620TensionFAERS: 1US FAERS
621Therapeutic response delayedFAERS: 1US FAERS
622Throat irritationFAERS: 1US FAERS
623ThrombocytopeniaFAERS: 1US FAERS
624Thyroid NeoplasmFAERS: 1US FAERS
625Thyroid cancer metastaticFAERS: 1US FAERS
626Tongue bitingFAERS: 1OFFSIDES
US FAERS
627Tongue discomfortFAERS: 1US FAERS
628ToothacheFAERS: 1US FAERS
629TorticollisFAERS: 1US FAERS
630Toxicity to various agentsFAERS: 1US FAERS
631Transient psychosisFAERS: 1US FAERS
632TrismusFAERS: 1US FAERS
633Trisomy 21FAERS: 1US FAERS
634UnemploymentFAERS: 1US FAERS
635UreterolithiasisFAERS: 1US FAERS
636Urethral StenosisFAERS: 1US FAERS
637Uterine CancerFAERS: 1US FAERS
638Uterine atrophyFAERS: 1US FAERS
639Vaginal DischargeFAERS: 1US FAERS
640Vaginal painFAERS: 1US FAERS
641Vascular compressionFAERS: 1US FAERS
642Vascular encephalopathyFAERS: 1US FAERS
643VasculitisFAERS: 1US FAERS
644VasospasmFAERS: 1US FAERS
645Venous occlusionFAERS: 1US FAERS
646VerbigerationFAERS: 1US FAERS
647VestibulitisFAERS: 1US FAERS
648Viral sinusitisFAERS: 1US FAERS
649Vulvovaginal discomfortFAERS: 1US FAERS
650Vulvovaginal pruritusFAERS: 1US FAERS
651Vulvovaginal swellingFAERS: 1US FAERS
652WeightFAERS: 1US FAERS
653WheezingFAERS: 1US FAERS
654jaundiceFAERS: 1US FAERS
655leiomyosarcomaFAERS: 1US FAERS
656skin abrasionFAERS: 1US FAERS
657Abnormal visionOFFSIDES
658Allergy to chemicalsCanada Vigilance: 1Canada Vigilance
659AmenorrheaOFFSIDES
660Ammonia increasedOFFSIDES
661Anal FissureOFFSIDES
662Anal abscessOFFSIDES
663AnhidrosisOFFSIDES
664Arteriosclerosis ObliteransOFFSIDES
665Aspiration PneumoniaOFFSIDES
666BiopsyOFFSIDES
667Bladder neck obstructionOFFSIDES
668Blood brain barrier defectOFFSIDES
669Blood cholinesterase decreasedOFFSIDES
670Blood count abnormalOFFSIDES
671Blood creatine abnormalCanada Vigilance: 1Canada Vigilance
672Blood iron decreasedOFFSIDES
673Blood iron increasedOFFSIDES
674Body fat disorderOFFSIDES
675Bone fragmentationOFFSIDES
676Bone swellingOFFSIDES
677Bone trimmingOFFSIDES
678BursitisOFFSIDES
679Carcinoembryonic antigen increasedOFFSIDES
680Cataract operationOFFSIDES
681Cerebral atrophyOFFSIDES
682Choking sensationOFFSIDES
683CholedocholithotomyOFFSIDES
684Chronic Obstructive Airway DiseaseOFFSIDES
685Compression fractureOFFSIDES
686ConfabulationOFFSIDES
687DebridementOFFSIDES
688Decreased LibidoOFFSIDES
689DemyelinationOFFSIDES
690Denture wearerOFFSIDES
691DiverticulosisOFFSIDES
692DiverticulumOFFSIDES
693Ear tube insertionOFFSIDES
694Ejection Fraction DecreasedOFFSIDES
695Endodontic procedureOFFSIDES
696EpiglottitisOFFSIDES
697Eustachian tube disorderOFFSIDES
698Exfoliative rashOFFSIDES
699Failure to ThriveOFFSIDES
700Fistula dischargeOFFSIDES
701Food AllergyCanada Vigilance: 1Canada Vigilance
702Gallbladder necrosisOFFSIDES
703Gastric ulcerOFFSIDES
704Gene MutationOFFSIDES
705Gingival blisterOFFSIDES
706Gingival erythemaOFFSIDES
707GlaucomaOFFSIDES
708HepatotoxicityOFFSIDES
709High frequency ablationOFFSIDES
710HydronephrosisOFFSIDES
711HyperkeratosisOFFSIDES
712HyperpigmentationOFFSIDES
713Hypocoagulable stateOFFSIDES
714HyporeflexiaOFFSIDES
715ImpetigoOFFSIDES
716Injection site dermatitisOFFSIDES
717Injection site hypersensitivityCanada Vigilance: 1Canada Vigilance
718Injection site infectionOFFSIDES
719Injection site vesiclesOFFSIDES
720Intermittent ClaudicationOFFSIDES
721Intestinal infarctionOFFSIDES
722Joint injuryOFFSIDES
723LaryngospasmOFFSIDES
724Life expectancy shortenedOFFSIDES
725Lung AbscessOFFSIDES
726LymphomaOFFSIDES
727Mastication disorderOFFSIDES
728Muscle FatigueOFFSIDES
729Muscle WeaknessOFFSIDES
730Narcotic intoxicationOFFSIDES
731Nephrogenic Fibrosing DermopathyOFFSIDES
732NeuroblastomaOFFSIDES
733ObstructionOFFSIDES
734Open woundOFFSIDES
735Oral Cavity FistulaOFFSIDES
736Oral polypectomyOFFSIDES
737OsteomyelitisOFFSIDES
738OsteotomyOFFSIDES
739Pain of skinOFFSIDES
740Pancreatic enzymes increasedOFFSIDES
741PeriodontitisOFFSIDES
742Polymyalgia RheumaticaOFFSIDES
743Poor personal hygieneOFFSIDES
744PriapismOFFSIDES
745Primary sequestrumOFFSIDES
746Prostatic ObstructionOFFSIDES
747Protein total increasedOFFSIDES
748PsoriasisCanada Vigilance: 1Canada Vigilance
749Pulmonary radiation injuryOFFSIDES
750Purulent dischargeOFFSIDES
751Rectal fissureOFFSIDES
752Residual urineOFFSIDES
753Retroperitoneal lymphadenopathyOFFSIDES
754SequestrectomyOFFSIDES
755Skin hypertrophyOFFSIDES
756Skin tightnessOFFSIDES
757SnoringOFFSIDES
758Synovial CystOFFSIDES
759TenosynovitisOFFSIDES
760Therapeutic procedureOFFSIDES
761Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
762ThrombophlebitisOFFSIDES
763Tolosa-Hunt SyndromeOFFSIDES
764Tooth ExtractionOFFSIDES
765Tooth InfectionOFFSIDES
766Ureteral stent insertionOFFSIDES
767Urethral fistulaOFFSIDES
768Vitamin A DeficiencyOFFSIDES
769Vitreous DetachmentOFFSIDES
770Weight GainOFFSIDES
771Wound DebridementOFFSIDES
772Wound closureOFFSIDES
773Wound dehiscenceOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.